Rhucin

conestat alfa · Pharming Technologies B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Rhucin, covering 2009-12-31 to 2015-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks [Phase 3]

See pricing